Observational studyCritical care (London, England)2026
Association between initial norepinephrine dose and minute by minute mean arterial pressure.
Observational study in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimizing Timing and Dose of Starting Norepinephrine and Vasopressin in Septic Shock.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeither the magnitude nor the timing of mean arterial pressure (MAP) increase after norepinephrine (NE) initiation is well defined, leaving clinicians without clear criteria for adequate starting doses. This study aimed to characterize minute-by-minute MAP responses to different initial NE doses in intensive care unit (ICU) patients with shock.
methodsWe included patients admitted to seven ICUs in Japan between 2013 and 2024 who had hypotension (MAP ≤ 65 mmHg) and initiated NE infusion more than 30 min after ICU admission. Invasive MAP data were collected during the observational period, defined as 30 min before to 120 min after NE initiation. Time-dependent effects were estimated with a generalized additive model adjusting for potential confounders, to evaluate MAP changes with varying starting NE doses.
resultsAmong the 81,829 patients, 5,349 who received NE were analyzed, of whom 2,006 (37.5%) had sepsis. Both the maximum MAP rise and the 15-min rate of increase were higher at an NE infusion rate of 0.100 µg/kg/min, compared with 0.025 and 0.050 µg/kg/min (p < 0.01). Model outputs indicated that NE infusion rates of 0.025 and 0.050 µg/kg/min failed to achieve a MAP ≥ 65 mmHg within 60 min when baseline MAP was below 53.9 and 48.4 mmHg, respectively. Failure to achieve MAP ≥ 65 mmHg within 60 min was independently associated with increased ICU mortality (odds ratio: 1.49 [1.27-1.76], p < 0.01). In sepsis, the initial MAP slope at 0.025 µg/kg/min was significantly smaller than in non-sepsis (p < 0.01).
conclusionHigher initial NE doses were associated with both larger and faster MAP increases. Lower starting doses appeared insufficient to achieve a target MAP within 60 min in patients with severe hypotension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.